Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation, Restricted Stock and Stock Options (Details 4)

v3.20.4
Stock-Based Compensation, Restricted Stock and Stock Options (Details 4) - Warrant [Member]
9 Months Ended
Dec. 31, 2020
USD ($)
$ / shares
shares
Shares Underlying Options  
Outstanding, Beginning | shares 1,281,852
Issued | shares 1,121,488
Exercised | shares (116,667)
Outstanding, Ending | shares 2,286,673
Exercisable | shares 2,186,719
Weighted Average Exercise Price  
Weighted Average Exercise Price Outstanding, Beginning | $ / shares $ 1.91
Weighted Average Exercise Price, Issued | $ / shares 4.65
Weighted Average Exercise Price, Exercised | $ / shares 3.00
Weighted Average Exercise Price Outstanding, Ending | $ / shares 2.66
Weighted Average Exercise Price, Exercisable | $ / shares $ 2.57
Weighted Average Remaining Contractual Term (Years)  
Outstanding, Beginning 3 years
Issued 4 years 10 months 25 days
Outstanding, Ending 3 years 9 months 18 days
Exercisable 3 years 9 months 18 days
Aggregate Intrinsic Value  
Outstanding, Ending | $ $ 2,918,734
Exercisable | $ $ 2,918,734